679 results on '"Budde, Ulrich"'
Search Results
2. Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019
3. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
4. Perioperative diagnosis and impact of acquired von Willebrand syndrome in infants with congenital heart disease
5. Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia
6. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study
7. Multifaceted pathomolecular mechanism of a VWF large deletion involved in the pathogenesis of severe VWD
8. Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial
9. Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients
10. Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
11. Shear-induced unfolding and enzymatic cleavage of full-length VWF multimers
12. Comparison of von Willebrand factor platelet‐binding activity assays: ELISA overreads type 2B with loss of HMW multimers
13. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study
14. Characterization of large in-frame von Willebrand factor deletions highlights differing pathogenic mechanisms
15. A multi‐center evaluation of TECHNOSCREEN® ADAMTS‐13 activity assay as a screening tool for detecting deficiency of ADAMTS‐13
16. Cytosorb Adsorption During Emergency Cardiac Operations in Patients at High Risk of Bleeding
17. Shear-Induced Unfolding Activates von Willebrand Factor A2 Domain for Proteolysis
18. Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission
19. The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance
20. Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels
21. Mutation G1629E Increases von Willebrand Factor Cleavage via a Cooperative Destabilization Mechanism
22. The search for the underlying mutations causing VWD in 13 Venezuelan families
23. Von Willebrand factor regulates complement on endothelial cells
24. A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malaria
25. von Willebrand factor is dimerized by protein disulfide isomerase
26. Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock
27. Elevated von Willebrand factor levels in multiple myeloma: Dysregulated mechanisms of both secretion and clearance
28. ADAMTS-13 activity in stroke of known and unknown cause: Relation to vascular risk factor burden
29. Acquired von Willebrand Syndrome in Patients With a Centrifugal or Axial Continuous Flow Left Ventricular Assist Device
30. Addition of in-vitro generated endothelial microparticles to von-Willebrand plasma improves primary and secondary hemostasis
31. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices
32. Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias
33. Acquired von Willebrand syndrome is common in infants with systemic-to-pulmonary shunts: Retrospective case-series
34. Blood Transfusion Ameliorates Free Haem-Induced Loss of Thrombomodulin and Endothelial Cell Activation in Paediatric Sickle Cell Anaemia
35. Exponential Size Distribution of von Willebrand Factor
36. Plasmin Cleaves Von Willebrand Factor at K1491-R1492 in the A1–A2 Linker Region in a Shear- and Glycan-Dependent Manner In Vitro
37. Bleeding diathesis in Noonan syndrome: Is acquired von Willebrand syndrome the clue?
38. Treatment Algorithm for Patients With von Willebrand Syndrome Type 2A and Congenital Heart Disease—A Treatment Algorithm May Reduce Perioperative Blood Loss in Children With Congenital Heart Disease
39. Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial
40. How I treat the acquired von Willebrand syndrome
41. MO149: Effect of Plasma Exchange on COVID-19 Associated Excess of Von Willebrand Factor and Inflammation in Critically Ill Patients
42. Additional file 1 of Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial
43. Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)
44. A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE
45. The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF
46. Flow-based measurements of von Willebrand factor (VWF) function: Binding to collagen and platelet adhesion under physiological shear rate
47. Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
48. ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19
49. Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS)
50. Report On Complete Endpoints and Predictors of Response to Plasma Exchange – Results From a Randomized Controlled Trial in Septic Shock Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.